Zhang, X., Zhou, F., Lu, T., Zhang, S., Wei, X., Qiu, X., . . . Zhuang, J. (2025). Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer. World Journal of Urology, 43(1), . https://doi.org/10.1007/s00345-024-05412-4
Chicago-referens (17:e uppl.)Zhang, Xuyu, Feng Zhou, Tong Lu, Shun Zhang, Xuedong Wei, Xuefeng Qiu, Linfeng Xu, Hongqian Guo, och Junlong Zhuang. "Neoadjuvant Darolutamide Plus Androgen Deprivation Therapy for High-risk and Locally Advanced Prostate Cancer." World Journal of Urology 43, no. 1 (2025). https://doi.org/10.1007/s00345-024-05412-4.
MLA-referens (9:e uppl.)Zhang, Xuyu, et al. "Neoadjuvant Darolutamide Plus Androgen Deprivation Therapy for High-risk and Locally Advanced Prostate Cancer." World Journal of Urology, vol. 43, no. 1, 2025, https://doi.org/10.1007/s00345-024-05412-4.
